Fatty Acid Biosynthesis Flashcards
(24 cards)
Functions of Lipids
- metabolic energy storage (triglycerides)
- components of biological membranes (phospholipids and glycolipids)
- cholesterol used in steroid hormones and bile acid biosynthesis
- Fat soluble vitamins (A, D, E, and K)
- Arachidonic acid (C20 FA) used in biosynthesis of prostaglandins and other bioactive compounds
- Phosphoinositides as precursors of second messengers molecules
Refsum’s Disease
- accumulation of phytanic acid in CNS. Phytanic acid is a branched fatty acid
- neurological defect
- specific enzymes are required for its degradation
- deficiency of such enzymes results in Refsum’s disease
FA biosynthesis
- occurs primarily in the liver, adipose tissue, CNS and lactating mammary glands
- needs acetyl CoA (as carbon source) and NADPH (as reducing power)
- FA biosynth enzymes are located in the cytoplasm
Acetyl CoA transport
- Glucose undergoes glycolysis and TCA cycle in the cytoplasm
- excess glucose–>fatty acid
- any acetyl CoA not oxidized by TCA cylce exits the mitochondira and is used for the synthesis of fatty acid (palmitate) and triglyceride
- Acetyl CoA must be converted to citrate to exit the mitochondria and enter the cytoplasm for FA biosynthesis
- isocitrate–(isocitrate dH)–>alpha KG; ATP inhibits isocitrate dH so the citrate level increases
- citrate enters the cytoplasm and is converted back to acetyl CoA and OAA using citrate lyase.
- acetyl CoA is used in FA biosynthesis
- OAA in cytoplasm–(malate dH; NADH–>NAD+)–>malate–(malic enzyme; NADP+–>NADHP)–>pyruvate; pyruvate is transported back into the mitochondria

NADPH for FA biosynthesis
- Comes from two sources:
- Pentose phosphate pathway
- recycling of OAA from cytoplasm to mitochondria

Synthesis of Malonyl CoA from acetyl CoA
- acetyl CoA–(acetyl CoA carboxylase ACC)–>malonyl CoA; acetyl CoA carboxylase requires biotin
- irreversible, rate-determining rxn; two-step process:
- ACC biotin is carboxylated; bicarbonate is source of CO2; ATP-dependent
- CO2 is transferred to acetyl CoA generating malonyl CoA.
- Malonyl can be decarboxylated to regenerate acetyl CoA by enzyme malonyl CoA decarboxylase (MCD)
- the activities of ACC and MCD are reciprocally regulated
- cellular level of malonyl CoA is dependent on ACC and MCD

Acetyl CoA Carboxylase isoforms
- ACC1
- cytosol; lipogenic tissues such as live, adipose, and lactating mammary gland
- ACC1-generated malonyl CoA is utilized exclusively for synthesis of FAs.
- ACC2
- mitochondrial membrane; oxidative tissues such as liver, skeletal muscle, and heart
- ACC-2 associated with carnitine/palmitoyl-transferase 1 (CPT1)
- ACC-2 generated malonyl CoA inihibits CPT1, preventing the entry of FAs into the mitochondria for ß oxidation and energy production
- ACC1 maintains regulation of FA synthesis; ACC2 regulates FA oxidation

ACC Allosteric Regulation
- Short-term
- ACC protomeric form=inactive; ACC polymeric form=active
- Both ACC regulated by diet and hormones such as insulin, glucagon, epinephrine and growth hormones.
- Citrate (precursor to acetyl CoA) activates ACC through a feed-forward loop by promoting polymerization
- Palmitoyl CoA (final product of fatty acid biosynth. and other short- and long- chain fatty acyl CoAs) inhibit ACC polymerization, reducing its activity.
ACC regulation by covalent modification
- Short term
- regulated by phosphorylation/dephosphorylation through hormone activities
- ACC-Phos=inactive; ACC=active
- carb rich diet–> increased insulin–>glycolysis–(+ enzyme Phosphatase)–>ACC active–>increased malonyl CoA–>FA synth
-
starvation, diabetes (low insulin and high glucagon/insulin ratio), and elevated epinephrine–(+ enzyme PKA)–>
- glycolysis inhibited, stimulate FA mobilization, phosphorylated ACC (inactive).

ACC regulation by AMPK
- Short term
-
AMP-activated protein kinase (AMPK) activated by high AMP/ATP ratio
during exercise
hormones and cellular stressors that deplete ATP- AMPK phosphorylates and inhibits ACC
during situations of increased energy demand–>AMPK activated–>increased oxidation of FA and decreased FA synth - AMPK also phoshporylates MCD, activating it–>decreased malonyl CoA–>increased FA oxidation
- AMPK phosphorylates and inhibits ACC

ACC Regulation Long-term regulation
- ACC1 and ACC2 genes expression regulated by diet and hormones
- Fat-free diet–>activates synthesis of ACC1 and ACC2 enzymes–>FA biosynth.
- Starvation or diabetes–>represses expression of ACC enzymes-->repressed FA synth and increased oxidation of FA
- insulin upregulates ACC1 promoter
- glucagon downregulates ACC1 promoter
- ACC isoforms are targets for developing drugs to regulate obesity, diabetes, cancer, and cardiovascular problems
FA synthase complex
- large, multifunctional dimer
- seven different enzymes and an acyl carrier protein (ACP); two of these (14 enzymes) form one FA synthase
- ACP and ketoacyl synthase provide thiol (-SH) groups for attachment of a malonyl and an acetyl group, repectively
- Two chains are synthesized simultaneously

FA biosynthesis
Rxn 1
Condensation
- malonyl group transferred to ACP of one monomer; acetyl group transferred ketoacyl sythase (KS) of the other monomer
- acetyl and malonyl groups are condensed to produce one molecule of acetocetyl-ACP (4C); one carbon lost as CO2
- Enzyme: ß ketoacyl-ACP synthase (KS); condensing enzyme

FA biosynthesis Rxn 2
Reduction
- Acetoacetyl-ACP (4C) is reduced to ß-hydroxybutyryl-ACP. One NADPH used
- Enzyme: ß-ketoacyl-ACP reductase (KR)

FA biosynthesis Rxn 3
Dehydration
- ß-hydroxybutyryl-ACP is dehydrated to crotonyl-ACP.
- One molecule of H2O is lost
- Enzyme: ß-hydroxyacyl-ACP dehydratase (DH)

FA biosynthesis Rxn 4
Reduction
- Crotonyl-ACP is reduced to butyryl-ACP.
- A second molecule of NADPH is used
- enzyme: Enoyl-ACP reductase (ER)

FA biosynthesis Elongation
- At the end of the first round of synthesis, butyryl-ACP (4C) is produced.
- next round, butyryl-ACP condenses with another molecule of malonyl-ACP, thus lengthening the chain by 2C
- The process of malonyl-ACP condensation continues until a 16C long palmitoyl-ACP is formed
- At this point, synthesis stops and the palmitic acid (16:0) is released from the FA synthase.
- Overall rxn for palmitic acid:
8 Acetyl-CoA + 14 NADPH + 14 H+ + 7 ATP–>Palmitic acid (16 C) + 8 CoA + 14 NADP+ +7 ADP + 7 Pi + H2O
*Note: 7 of the 8 acetyl-CoA are converted to malonyl-CoA before they are used for FA biosynthesis
Carbon labeling in FA biosynth and elongation

FA synthase Regulation
- Transcriptionally regulated:
- In liver:
- FAS synthase expression stimulated by insulin
- insulin effect mediated by transcription factors USFs (upstream stimulatory factors) and SREBP-1 (sterol response element binding proteins)
- PUFA (poly-unsaturated fatty acids) diminish the transcriptiof FAS gene.
- In fat cells:
- Leptin inhibits expression of FAS
- Leptin regulates food intake and fat metabolism
- Leptin is produced by fat cells inresponse to excess body fat–diminished FA synthesis
- In liver:
Elongation of FA
- Palmitate (16:0) can be elongated to give longer-chain FAs through elongases
- In ER:
- Malonyl-CoA serves as the 2C donor
- In mitochondria:
- Preexisting short- and medium-chain FAs are elongated in the mitochondria
- Acetyl-CoA serves as the 2C donor
Desaturation of FA
- FA can be desaturated to yield unsaturated FA
- enzymes: desaturases
Saturated FA + O2 + NADH + H+ —(enzyme: Desaturase)–>Mono-unsaturated FA + NAD+ + H2O
- This reaction can be repeated to produce polyunsaturated FAs
- Mammals only have four desaturases: 9-, 6-, 5-, and 4- fatty acyl-CoA desaturases
- Mammals can’t add double bonds beyond C9.
- Linoleic acid (18:2 delta9,12) and Linolenic acid (18:3 delta9,12,15) are considered essential in diet
- these are precursors for arachidonic acid (EPA and DHA)
Synthesis of Triacylglycerols (triglycerides) Location
- FA must be activated first by the addition of CoA; requires 1 ATP
- Synthesized in liver (primarily) and adipose tissue from fatty acyl-CoA and glycerol 3-phosphate
- In liver, Gly3P is produced by phosphorylation of glycerol by glycerol kinase, or by reduction of DHAP by Gly3P dH
- TGs are packaged to form very low density lipoproteins (VLDL)
- VLDL delivers newly synthesized TGs to the peripheral tissues
- In adipose tissue, no glycerol kinase
- Gly3P produced from reduction of DHAP by Gly3P dH.
- therefore, adipose tissue only synthesize and store FAs in the fed state when the glucose supply is plentiful
- TGs are stored in cytosol until needed for energy production
Synthesis of Triglycerides (TGs)

Subcellular location of biochemical processes related to lipid metabolism
